title: Radiolabelling of Lipiodol with generator-produced 188Re for hepatic tumor therapy.
abstract: In this study we prepared and analyzed the biodistribution of 188Re-labelled Lipiodol ([188Re]-Lipiodol) in rats after intrahepatic arterial injection. EDTB was synthesized by condensation of 1,2-benzenediamine and ethylenediaminetetraacetic acid (EDTA). The labelling efficiency of [188Re] Lipiodol was determined to be greater than 97% by ITLC developed with n-hexane. Following incubation of the [188Re] Lipiodol with an equal volume of serum at 37 degrees C for 48 h, ITLC indicated good in vitro stability. Approximately 7.4 MBq [188Re] Lipiodol was injected in each rat via the hepatic artery and samples of liver, spleen, muscle, lung, kidney, bone, whole blood and testis were obtained. [188Re] Lipiodol tissue concentrations showed that after 1 h intrahepatic injection most of the radiotracer was retained in the liver, and was eliminated slowly with a biological half-life of 33.5 h. Radioactvity levels in the lung, kidney and blood were moderate at 1 h, and declined rapidly over time. In the spleen, muscle, testis and bone, radiation levels were insignificant. These initial results indicate that -188Re- Lipiodol may be a potential radiopharmaceutical agent for the treatment of liver tumors.
authors.affiliation: Department of Nuclear Medicine, Veterans General Hospital-Taichung, Taiwan.
authors.forename: S J
authors.initials: SJ
authors.lastname: Wang
authors.forename: W Y
authors.initials: WY
authors.lastname: Lin
authors.forename: M N
authors.initials: MN
authors.lastname: Chen
authors.forename: B T
authors.initials: BT
authors.lastname: Hsieh
authors.forename: L H
authors.initials: LH
authors.lastname: Shen
authors.forename: Z T
authors.initials: ZT
authors.lastname: Tsai
authors.forename: G
authors.initials: G
authors.lastname: Ting
authors.forename: F F
authors.initials: FF
authors.lastname: Knapp
mesh_terms: D000818:Animals; D004337:Drug Carriers; D004355:Drug Stability; D006499:Hepatic Artery; D006801:Humans; D007269:Injections, Intra-Arterial; D007459:Iodized Oil / Q000008:administration & dosage; D008113:Liver Neoplasms / Q000532:radiotherapy; D008114:Liver Neoplasms, Experimental / Q000378:metabolism / Q000532:radiotherapy*; D008297:Male; D011868:Radioisotopes / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012211:Rhenium / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014018:Tissue Distribution
chemical_list: D004337:Drug Carriers; D011868:Radioisotopes; D012211:Rhenium; D007459:Iodized Oil